ALKS 8700

ALKS 8700 · Biogen

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ALKS 8700, covering 2020-07-14 to 2022-06-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1 [Phase 3]